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Background: Idiopathic juvenile osteoporosis (IJO) is a rare condition of poorly understood etiology and
pathophysiology that affects otherwise healthy children. This condition is characterized clinically by bone pain and
vertebral fractures; spontaneous recovery is observed after puberty in the majority of cases. Although decreased
trabecular bone turnover has been noted previously, cortical and trabecular bone characteristics as determined by
quantitative computed tomography (QCT) and their relationship to bone histomorphometry are unknown.
Methods: All children with a clinical diagnosis of IJO who were followed in our center since 1995 and who had
undergone at least one diagnostic bone biopsy were included in this cross-sectional analysis.
Results: Fifteen patients (11 males/4 females) with median ages of 5.8 and 10.2 years at first symptoms and at
referral, respectively, were included in the analysis. Histomorphometric analysis demonstrated decreased trabecular
bone turnover (BFR/BS) in the majority of patients with heterogeneous parameters of trabecular mineralization and
volume. QCTresults demonstrated that bone mineral density (BMD) was reduced in both trabecular/lumbar and
cortical/femoral bone: Z score: -2.1 (−3.6;–1.0) and −0.9 (−8.2;1.4)in the two compartments, respectively. In the eight
patients who underwent both bone biopsy and QCT, cortical BMD was associated with trabecular separation and
with trabecular bone formation rate (r = 0.898 and −0.881, respectively, both p < 0.05).
Conclusions: This series confirms that IJO is characterized by impaired trabecular architecture that can be detected
by both bone biopsy and QCT. The association between bone biopsy and QCT results may have implications for
diagnosis, treatment, and follow-up of these children.
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Osteoporosis, a well-known and frequent condition in
postmenopausal women, rarely affects children but may
be seen in primary genetic conditions involving the
skeleton or the connective tissue, such as for example
OsteogenesisImperfecta, Bruck syndrome, Osteoporosis
Pseudoglioma Syndrome, Ehlers-Danlos syndrome, Marfan
syndrome and Homocystinuria, or may be secondary* Correspondence: kwesseling@mednet.ucla.edu
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reproduction in any medium, provided the orto chronic inflammation, glucocorticoid therapy, and
prolonged immobilization [1]. In contrast to these
relatively well defined pathologies, the pathophysiology
of idiopathic juvenile osteoporosis (IJO), a rare condition
characterized clinically by the insidious onset of bone pain
followed by vertebral compression and long bone
fractures, remains unknown.
The diagnosis of IJO is made clinically. Children of
both genders present two to three years before the onset
of puberty with an insidious onset of pain in the back and
lower limbs in association with vertebral compression
fractures, trouble ambulating and long bone fractures,ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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absence of family history of childhood bone disease,
extra-skeletal manifestations, or growth impairment
[2]. Although bone histomorphometry is the gold
standard for the diagnosis of skeletal pathology, bone
histomorphometric features of IJO have been characterized
in only one series of 9 patients with IJO; this series
reported a decrease intrabecular bone volume, thickness
and number with impaired trabecular bone turnover but
without any alterations in cortical bone [3,4].
Osteopenia is evident on radiographs; however, the
true extent of osteoporosis and osteopenia in patients with
IJO is unknown. Indeed, previous studies have evaluated
bone density using dual energy X-ray absorptiometry
(DXA), a technique that does not discriminate between
cortical and trabecular bone density and whose assessment
of bone mineral density as an area BMD (g/cm2) are
affected by bone size, body size and composition [5]. By
contrast, Quantitative Computed Tomography (QCT), a
three dimensional technique based on standard body CT
scanners, separately measures trabecular and cortical
volumetric bone mineral densities (BMD) at central sites
(lumbar spine and hip), thus permitting the accurate
evaluation of bone size, geometry, and density in both
trabecular and cortical bone compartments [6]. Although
this technique has the potential to provide accurate
assessment of cortical and trabecular bone density in
the IJO population, QCT has never been evaluated in
IJO patients, and never compared to the reference
standard, bone biopsy. The aim of this study was
therefore to report a single-centre experience of IJO in
a cohort of 15 patients with at least one bone biopsy,
using both histomorphometry and a non-invasive
three-dimensional bone imaging technique, i.e., QCT.
Methods
All patients with a diagnosis of IJO who were followed
in our center from 1995 through 2010 and who had
undergone at least one bone biopsy for clinical diagnosis
were included in this retrospective descriptive analysis.
This study was approved by the UCLA Human Subject
Protection Committee.
The diagnosis of IJO was based on the following
criteria: clinical symptoms of bone disease in a previously
healthy child (e.g., past history of fractures, osteopenia,
bone pain), evidence of low bone mass on BMD assessed
by QCTand/or of osteoporosis on bone histomorphometry,
without any evidence for a secondary osteoporosis or other
primary bone disease. A clinical score was developed
which accounted for the subjective severity of disability
(moderate or severe restriction of daily activities) and
the objective number of fractures. Children were
divided into two groups based on number of fractures:
moderate disability was defined as fewer than fivefractures (clinical score 1) while severe disability was
defined as 5 or more fractures (clinical score 2).
QCT examination was performed at three sites (both
femora and the spine) using the same scanner (General
Electric Hilite Advantage, Milwaukee, WI) in all patients.
Measurements of the size (i.e., cross-sectional area, CSA)
and the density of cortical bone were obtained from a
1.5 mm-thick sections at the midshaft of the femora at 120
kVp and 70 mA; the final results consisted in the mean of
both femora. Measurements of the size (i.e., cross-sectional
area CSA) and the density of cancellous bone were
obtained from 10 mm-thick imaging sections at the mid-
portions of the first four lumbar vertebrae at 80 kVp and
70 mA; the final results consisted in the mean of L1, L2, L3
and L4 values. Reference values assessed with QCT are
2000 ± 60 mg/cm3for cortical BMD in all children, and
250 ± 45 and 285 ± 45 mg/cm3 for cancellous BMD in
pre-pubertal and pubertal children, respectively. These
local reference values are routinely used by Dr. Gilsanz,
and trabecular BMD details have been described from a
cohort of 1222 White healthy subjects aged 5–21 years
[7]. Z-scores were calculated with the following formula:
Z-score = (Result of the patient – Mean of the control
population)/SD of the control population. The radiation
exposure per measurement was 1 mSv at the spine and
1.5 mSv at the femur. The variation in this technique is
less than 1.5% in children [8].
The full thickness bone biopsy, performed at the iliac
crest 2 to 5 days after the end of a double tetracycline
labeling (10–15 mg/kg per day, taken orally three times
a day during two 2-day periods separated by a 10 to 12-
day free interval), was performed as previously reported
[9]. Biopsy specimens 0.5 cm in diameter by 1 to 2 cm
in length were fixed in 10% phosphate-buffered formalin
for 48 hours, then dehydrated in alcohol, cleared with
xylene, and embedded in methylmethacrylate. Static
histomorphometric parameters were evaluated in lamellar
portions of undecalcified 5 μm sections treated with
Goldner stain and tetracycline labeling was assessed in
unstained 10 μm sections of lamellar bone, by the same
observer (RP). Bone histology was reported using the
terminology established by the Nomenclature Committee
of the American Society of Bone and Mineral Research
[10]. Derived indices were calculated by additional formu-
las, as detailed previously [11]. Normal pediatric values for
all histomorphometric parameters were previously obtained
from double-tetracycline-labeled iliac crest bone biopsies
from 31 pediatric controls (mean age 12.4 ± 8.9 years, 71%
males, 48% Caucasian, 26% Hispanic) who were undergoing
elective orthopedic surgery [12,13].
Statistical analysis was performed using the SPSS
softwareW 18.0 for Windows. Comparisons between groups
were performed using the nonparametric Wilcoxon signed
rank test. Bivariate correlations were computed with the
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with a chi-square test. All statistical tests were performed
at the two-sided 0.05 level of significance. Results are
presented as median (range).
Results
Fifteen patients (11 males/4 females) with at least one
bone biopsy were included in the analysis; only 12 initial
bone biopsies were interpretable as one biopsy contained
growth plate and two were technically unreadable.
Eleven patients had an initial QCT. Eight patients
underwent both baseline QCT and bone biopsy.
Patients
The median (range) for age at first symptoms and for
age at referral were 5.8 (1.5–14) and 10.2 (5.5-15.4)
years, respectively. The median time between first
symptoms and the diagnosis of IJO was 3.5 (0.2-9.4)
years. The median (range) percentile of height at referral
was 88 (15–98); 11 patients were at or above the 50th
percentile for height at diagnosis. Twelve patients were
White, two were Hispanic and one was White by her
father and Hispanic by her mother.
Most of the patients had a family history of bone
disease or disorder of calcium/phosphate metabolism,
including post-menopausal osteoporosis in four, scoliosis
in one, and parathyroid adenoma in one. Two patients
were siblings and two others were homozygous twins.
Ten patients underwent fibroblast analysis or direct gene
analysis to rule out Osteogenesis Imperfecta. All but one
patient had a history of fractures occurring with minimal
trauma; five complained of back pain and four of leg
pain. Two patients had kyphosis or scoliosis, two had
vertebral compression fractures and one developed
avascular necrosis and osteomyelitis. Of note, one
patient received calcitonin prior to referral; even though
calcitonin is known to have inhibitory effects on osteoclast
activity [14,15], it is difficult to evaluate in which extend
this treatment could have attenuated the severity of the
bone impairment at baseline. Table 1 summarizes the
main clinical characteristics of the patients.
Bone histomorphometry
Trabecular bone histomorphometric parameters of
turnover, mineralization and volume parameters are
summarized in Tables 2 and 3. Bone turnover (BFR/BS)
was decreased in 5 patients while parameters of trabecular
mineralization and volume were heterogeneous. Figure 1
presents morphological findings of IJO in comparison to
normal age-matched bone.
Biochemical parameters
Biochemical abnormalities were found in five patients:
one displayed transient hypercalciuria, two had increasedlevels of urinary N-telopeptide, one was 25 (OH) vitamin
D deficient (defined by a 25 (OH) vitamin D level of
22 ng/mL) and one had a moderate but transient
increase in PTH (120 pg/mL). The median (range) for
PTH and 25 (OH) vitamin D at the time of the bone
biopsy were 26 (8–120) pg/ml and 44 (22–93) ng/ml,
respectively. Serum PTH levels were directly related to
trabecular bone volume (BV/TV, r = 0.670, p = 0.024),
and 25 (OH) vitamin D levels were associated with the
rate of bone mineralization (osteoid maturation time
(OMT), r = −0.786, p = 0.036 with a similar trend for
mineralization lag time (MLT), r = −0.714, p = 0.07),
although not with osteoid accumulation (as measured by
osteoid volume (OV/BV), osteoid thickness (O.Th), or
osteoid surface (OS/BS)).
Quantitative computed tomography (QCT)
Trabecular (lumbar) and cortical (femoral) bone mineral
density were both low at 187 (124–224) mg/cm3 and
1946 (1506–2081) mg/cm3, respectively, with a Z-score
of −2.1 (−3.6;–1.0) and −0.9 (−8.2;1.4), respectively.
Trabecular (lumbar) and cortical (femoral) cross sectional
area were 11.35 (4.72–12.69) cm2 and 4.81 (1.86–6.61) cm2,
respectively; Z-score according to age and body weight
for these two parameters were 2.30 (range −0.8, 4.4)
and −0.7 (−3.0, 0.9), respectively. There was no significant
association between cortical and trabecular bone mineral
densities (r = 0.395, NS).
QCT and bone histomorphometry
A comparison of the eight patients who had both bone
biopsy and QCT within a median time frame between
the two examinations of 0.4 years (0.1–2.5) revealed a
relationship between cortical bone mineral density and
parameters of trabecular bone volume (trabecular number
(Tb.N): r = 0.898, p = 0.02; trabecular separation (Tb.Sp):
r = −0.838, p = 0.009), with a trend between cortical bone
mineral density and cortical bone volume (external
bone volume (BV/TV) and external porosity, r = 0.754
and −0.754, respectively, both p = 0.084). Trabecular
bone mineral density was associated with trabecular
bone turnover (trabecular bone formation rate (BFR/BS):
r = −0.881, p = 0.004). Figure 2 illustrates the relationship
between trabecular bone mineral density and BFR/BS.
Table 4 summarizes the QCT and bone biopsy results
per patient.
Clinical severity score
The proportion of boys with clinically severe idiopathic
juvenile osteoporosis was higher than the proportion of
boys with clinically moderate disease. There were no
imaging differences between the two groups to account
for the clinical findings; however, patients with severe
osteoporosis had significantly lower mineralization lag




























1 M 3 fractures mother,
brother of pt2
Negative 2 15.4 6.0 9.4 90 fracture No No No No Increased urinary NTX
2 F Osteoporosis
mother, sister of pt1
NP 1 13.5 5.0 8.5 45 back pain Yes No No No Transient hyperPTH
3 M No Negative 2 8.2 2.5 5.7 95 fracture No No No No No
4 M Osteoporosis
grand-mother
Negative 2 14.3 14.0 0.3 85 fracture Yes Yes No No Increased urinary NTX
5 F No Negative 1 5.9 5.5 0.4 50 fracture No No No No No
6 M Osteoporosis
grand-mother
NP 1 13.3 10.5 2.8 75 fracture No No No No No
7 F No Negative 1 7.8 7.6 0.2 90 osteopenia No No No No No
8 M Rheumatoidarthritis
mother




Negative 2 10.2 3.5 6.7 90 fracture No No No No No
10 M Twin brother (pt 11)
with fractures
Negative 2 13.9 5.0 8.9 98 fracture No No No No No
11 M Twin brother (pt 10)
with fractures
Negative 1 13.9 13.0 0.9 98 fracture No No No No No
12 M Osteoporosis
grand-mother
Negative 2 5.5 1.5 4.0 15 fracture No Yes No No No
13 M Scoliosis father NP 2 8.1 5.0 3.1 95 fracture Yes No Yes Yes No
14 M No NP 2 9.5 9.0 0.5 15 fracture Yes Yes Yes Yes Osteomyelitis radius and
avascular necrosis,
Transient hypercalciuria
15 F NA NA 2 10.0 NA NA NA fracture NA NA NA NA NA




















Table 2 Baseline bone biopsies findings in 12 patients with IJO
Parameter Median Minimum Maximum Normal range (10–11)
Volume Trabecular separation (Tb.Sp) (μm) 432 367 610 299–587
Trabecular number (Tb.N) (#/mm) 1.83 1.42 2.14 1.3–2.7
Trabecular thickness (Tb.Th) (μm) 107 79 145 72–177
Bone volume (BV/TV) (%) 19.71 13.61 26.8 9.3–22.7
Mineralization Mineral apposition rate (MAR) (μm/day) 0.8 0.5 0.99 0.9–2.4
Mineralization lag time (MLT) (days) 18.13 4.59 105.12 4.1–71.7
Osteoid maturation time (OMT) (days) 8.68 4.11 15.57 1.9–10.4
Osteoid thickness (O.Th) (μm) 6.92 2.73 9.61 3–13.9
Osteoid volume (OV/BV) (%) 1.21 0.26 4.65 0.2–5.86
Osteoid surface (OS/BS) (%) 8.69 3.15 30.39 1.4–23.96
Turnover Bone formation rate (BFR/BS) (μm2/mm3/year) 12.81 1.95 78.91 10–73.4
Eroded surface (ES/BS) (%) 4.28 0 13.27 1.6–6.84
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(28.8–105.1) and 12.4 (4.6–58.3) days in moderate and
severe osteoporosis, respectively (p = 0.028).
Discussion
This study is the first to compare QCT, which allows
separate measurements of cortical and trabecular bone
mineral density, with bone biopsy, the reference standard
for evaluating bone, in a cohort of 15 children with
idiopathic juvenile osteoporosis. Major findings include the
description of decreased bone turnover in many patients, a
decrease in both trabecular and cortical Z-scores for bone
mineral density, and a relationship between both cortical
and trabecular bone density with parameters of bone
histology, thus allowing a non-invasive evaluation of
cortical and vertebral bone volume in these children.
Two large clinical cohorts of IJO patients have been pre-
viously reported, containing 21 and 61 patients respectivelyTable 3 Qualitative abnormalities of bone mineralization,
turnover and volume in 12 IJO patients with bone
biopsies
High Low
Mineralization Mineralization lag time (MLT) 1 1
Osteoid maturation time (OMT) 4 0
Osteoid thickness (O.Th) 0 1
Osteoid surface (OS/BS) 3 0
Osteoid volume (OV/BV) 0 0
Volume Bone volume (BV/TV) 5 0
Trabecular thickness (Tb.Th) 0 0
Trabecular separation (Tb.Sp) 1 1
Trabecular number (Tb.N) 0 0
Turnover Mineral apposition rate (MAR) 0 7
Eroded surface (ES/BS) 5 3
Bone formation rate (BFR/BS) 2 5
Figure 1 Bone biopsy (Goldner'strichrome, magnification 40x)
showing in red, the unmineralized matrix and in green the
mineralized bone matrix. A- in a healthy control: the trabecular
micro-architecture and connectivity are normal. B- in a patient with
IJO: in addition to a global thinning of the trabeculae, there are
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Figure 2 Relationship between trabecular BMD at the spine (QCT) and BFR/BS on bone biopsy (r = −0.881, p = 0.004). BMD: bone
mineral density. QCT: quantitative computed tomography. BFR/BS: bone formation rate/bone surface.
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cohort was similar to these previous studies by Smith et al.
[16], and Lorenc et al. [17]; however, a greater proportion
of males (73%) was present in the current study with a
significantly greater number of males presenting with
clinically severe osteoporosis. Of note, the majority of
patients in the current cohort demonstrated normal or
high height percentile for age at referral; this clinical
feature may distinguish idiopathic juvenile osteoporosis
from other constitutional bone diseases at the time of
the first evaluation.
Histomorphometric data from Rauch et al. have des-
cribed the presence of decreased bone formation, in the
absence of increased bone resorption or cortical damage,













1 15.5 21.24 3.14 5.72 9.52
2 14.6 20.27 9.00 5.23 36.34
3 8.2 18.12 7.14 15.51 4.59
4 14.6 26.15 30.39 78.91 13.52
5 6.0 17.42 7.38 1.95 105.12
6 13.8
7 8.6 16.96 25.63 15.62 28.77
8 12.9 20.52 8.38 19.60 11.27
9 10.5 19.13 12.46 26.93 11.22
10 13.9 18.12 7.70 8.91 22.74
11 13.9
12 5.7 13.60 4.88 10.11 6.07
13 8.3 23.61 13.23 16.52 23.30
14 13.8
15 10.0 26.79 19.34 9.41 58.33osteoporosis [4]. They thus hypothesized that the condi-
tion may be due to the presence of an apparently normal
number of osteoblasts whose function is altered, leading
to a decreased rate of matrix deposition [3]. In the
current study, we have confirmed the findings by
Rauch et al. demonstrating decreased bone turnover in
the majority of patients; however, a greater variability
in mineralization and volume parameters were noted
in our cohort. In comparison with Rauch et al.,
histomorphometric parameters of trabecular bone turnover,
mineralization, and volume were higher in the current
cohort. These discrepancies may be explained in part by
the differences between the reference values.
Published data on bone mineral density in children










14.5 185 −2.22 1946 −0.90
12.8 193 −2.04 2081 1.35
6.3 205 −1.00 1981 −0.32
13.6 224 −1.36 1988 −0.20
11.8 124 −3.58 1934 −1.10
15.9 201 −1.87 1898 −1.70
14.1 198 −1.93 1916 −1.40
14.1 187 −2.18 2015 0.25
5.5 156 −2.09 1506 −8.23
7.9 141 −2.42 1916 −1.40
9.5 143 −2.38 1950 −0.83
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that total body bone mineral density was lower than the
normal for age [17]. Although it has been widely used in
children, the areal measurement of bone mineral density
by DXA has at least two main limitations in children: its
reliance on areal density rather than volumetric density, a
parameter which is modified by growth, and its inability
to distinguish between trabecular and cortical bone
compartments which have different physiology and
growth patterns [6,18]. More recently, Mayranpaa et al.
performed DXA and bone biopsy in a cohort of 24
consecutive children (17 males, median age 12 years)
presenting with idiopathic osteoporosis. They showed that
histomorphometric findings correlated poorly with frac-
ture history, circulating bone biomarkers and DXA
findings; in contrast, vitamin D deficiency and low lumbar
BMD were associated with high bone turnover on the
biopsy [19]. In this series, we also found an association
between vitamin D status and bone biopsy results, with a
relationship between 25 (OH) vitamin D levels and bone
mineralization. We also found a direct link between serum
PTH levels and trabecular bone volume that were not
described in the Finnish study.
In the current study, which used QCT to discriminate
cortical and cancellous bone compartments, a decrease
in both trabecular and cortical BMD Z-scores was
observed, with greater impairments in trabecular BMD,
confirming previous reports which highlighted the
greater importance of impaired trabecular bone in
patients with idiopathic juvenile osteoporosis. However,
the low Z-score for both BMD and cross-sectional area
in the cortical compartmentmay explain the important
frequency of cortical fractures also observed in this cohort;
indeed, even though children with IJO are usually known
to present both vertebral compression fractures and long
bone fractures, in our series, only two patients presented
with vertebral compression fractures whereas long bone
fractures and extremity fractures (e.g., toes, metatarse) were
much more frequent; however, due to the retrospective
design of the study, compression fractures were not
systematically screened in the patients, but only in case of
clinical symptoms. Furthermore, the association between
histomorphometry and QCT parameters highlights the
potential interest of this non-invasive three-dimensional
imaging technique for the follow-up of children with IJO.
In some patients the biopsy and QCT were not obtained
at the same age due to the retrospective design of the
study and may have lessened the association between QCT
and bone biopsy; however, to the best of our knowledge,
this association between QCT and bone biopsy has never
been evaluated in pediatrics and further prospective studies
are warranted to evaluate its potential clinical and thera-
peutic ramifications. Moreover, after the new definition in
2000 of osteoporosis by the National Institute of Health(NIH), adding ‘quality’ criteria in addition to the
quantitative evaluation of BMD, new bone imaging
techniques have been developed, including High-
Resolution peripheral Quantitative Computed Tomography
(HR-pQCT), and therefore leading to an improvement in
bone evaluation. Indeed, HR-pQCT can assess both com-
partmental (i.e., total, cortical and trabecular) volumetric
BMD and trabecular microarchitecture [6]. This technique,
corresponding to an improvement of QCT, has already
been validated in other pediatric populations [20,21]; it
could theorically be of interest in patients with IJO and
should be evaluated in the future.
Recent studies have reported an association between
mutations in the low-density lipoprotein receptor-
related protein 5 (LRP5) and low bone mass in children
[22]; however, these data cannot fully explain the patho-
physiology of juvenile osteoporosis, and the initial
trigger of the decreased osteoblast performance remains
to be determined. In the context of idiopathic juvenile
osteoporosis, Laine et al. recently described a higher
prevalence of LRP5 polymorphisms in a cohort of 27
children (14 males) [23]. Notably, they also found that
one-third of the patients had at least one parent with a
BMD below the expected range for age [23]. In our
series of case, ten patients underwent fibroblast analysis
or direct gene analysis to rule out Osteogenesis
Imperfecta but other genes were not studied. We also
found a positive familial history of bone disease in more
than half of our patients.
Currently, no evidence-based guidelines exist for the
management of idiopathic juvenile osteoporosis. Some
case reports have described the potential benefit of
bisphosphonate therapy [24-26]; however, few controlled
studies exist in the use of bisphosphonates in children in
general and in those with juvenile osteoporosis in particular
and the use of bisphosphonates in this population remains
controversial due to inadequate long-term efficacy and
safety data. Dietary and life-style modifications, including
adequate calcium and vitamin D intake, adequate exercise,
and avoidance of obesity, may be adopted in all children,
including those with IJO, with very little risk. Indeed, the
prevalence of 25 (OH) vitamin D deficiency in the current
cohort and the association between 25 (OH) vitamin D
levels and parameters of skeletal mineralization suggest that
early detection and treatment of vitamin D deficiency and
insufficiency may be beneficial in this patient population.
Conclusions
In conclusion, idiopathic juvenile osteoporosis is a rare
bone disease affecting pre-pubertal children, with both
cancellous and cortical impairments. Its etiology and
pathophysiology are not well understood and its diagnosis
remains one of exclusion. The current study brings new
insights into this rare disease, confirming bone impairment
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allowing the description of a promising association
between bone histology and QCT results that could be of
relevance in daily practice.
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